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AbstrAct
Objective To determine if use of point of care testing 
(POCT) is less costly than laboratory testing to the National 
Health Service (NHS) in delivering the NHS Health Check 
(NHSHC) programme in the primary care setting.
Design Observational study and theoretical mathematical 
model with microcosting approach.
setting We collected data on NHSHC delivered at nine 
general practices (seven using POCT; two not using POCT).
Participants We recruited nine general practices offering 
NHSHC and a pathology services laboratory in the same 
area.
Methods We conducted mathematical modelling 
with permutations in the following fields: provider type 
(healthcare assistant or nurse), type of test performed 
(total cholesterol with either lab fasting glucose or HbA1c), 
cost of consumables and variable uptake rates, including 
rate of non-response to invite letter and rate of missed 
[did not attend (DNA)] appointments. We calculated total 
expected cost (TEC) per 100 invites, number of NHSHC 
conducted per 100 invites and costs for completed NHSHC 
for laboratory and POCT-based pathways. A univariate and 
probabilistic sensitivity analysis was conducted to account 
for uncertainty in the input parameters.
Main outcome measures We collected data on cost, 
volume and type of pathology services performed at 
seven general practices using POCT and a pathology 
services laboratory. We collected data on response to the 
NHSHC invitation letter and DNA rates from two general 
practices.
results TEC of using POCT to deliver a routine 
NHSHC is lower than the laboratory-led pathway with 
savings of £29 per 100 invited patients up the point of 
cardiovascular disease risk score presentation. Use of 
POCT can deliver NHSHC in one sitting, whereas the 
laboratory pathway offers patients several opportunities to 
DNA appointment.
conclusions TEC of using POCT to deliver an NHSHC in 
the primary care setting is lower than the laboratory-led 
pathway. Using POCT minimises DNA rates associated with 
laboratory testing and enables completion of NHSHC in one 
sitting.
IntrODuctIOn
Cardiovascular disease (CVD) is a major 
cause of disability and premature mortality 
worldwide accounting for around one-third 
of all deaths annually in England.1 2 The 
National Health Service (NHS) Health 
Check programme is a national CVD primary 
prevention programme in England launched 
by the Department of Health in April 2009.3 
The programme aims to prevent heart 
disease, stroke, diabetes and kidney disease 
while reducing health inequalities.4 People 
aged 40–74 years and free of vascular disease 
diagnosis are eligible for an NHS Health 
Check. The programme uses information 
from the Health Check to calculate a CVD 
risk score. People at increased risk of CVD 
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Research
strengths and limitations of this study
 ► This is the first study describing cost savings to the 
NHS in delivering an NHS Health Check using POCT 
in the primary care setting.
 ► The mathematical model was based on observed 
response rates to NHS Health Check invite letters 
and missed appointments in POCT pathway and 
costs of phlebotomy and POC testing.
 ► This study only looked at the cost-saving use of 
POCT up to the point of cardiovascular disease 
risk score presentation and did not include full 
health economic modelling to determine cost-
effectiveness.
 ► Traditional laboratory-led pathway offers up to 
three times more opportunities for a patient to miss 
an NHS Health Check appointment or to exit the 
care pathway compared with POCT pathway. This 
enables general practices to act as a ‘one stop shop’ 
to patients wishing to undertake their Health Check 
in one sitting.
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are offered statins, advice and behaviour change support 
for lifestyle-related factors, including smoking, physical 
activity, alcohol consumption and diet. The programme 
has a potential to prevent 1600 heart attacks and strokes, 
650 premature deaths and over 4000 new cases of 
diabetes each year.5 The projected programme cost is 
£180–£243 million/year at full implementation with esti-
mated cost per quality adjusted life year (QALY) being 
£30006.
The programme is currently delivered in general prac-
tice (GP) using both laboratory and point-of-care testing 
(POCT) equipment to assess blood sugar (glucose or 
HbA1c) and total cholesterol levels. GPs relying on labo-
ratories first schedule phlebotomy tests and afterwards 
conduct the full NHS Health Check using glucose and 
cholesterol readings to calculate and communicate CVD 
risk. This approach of delivering the programme requires 
the patient to come back for another visit following labo-
ratory testing to complete the NHS Health Check and 
delays the communication of CVD risk to patients. The 
NHS Health Check programme delivered using POCT 
equipment obtains immediate total cholesterol and 
glucose/HbA1c results using blood samples taken from 
‘finger pricking’ patients. The use of POCT facilitates 
communication of CVD risk score to patients in a single 
visit.
According to the results of a national study, coverage 
defined as the proportion of total eligible population who 
attended an NHS Health Check was low (21.4%) in the 
first 4 years after programme implementation.7 Further, 
only one-third of attendees at high risk were prescribed 
a statin after the NHS Health Check.8 Another national 
study found coverage to be low in the first 4 years but 
steadily rising from 5.8% in 2010 to 30.1% in 2012. Of 
those found to be at high CVD risk (≥20%, 10-year risk) 
when attending an NHS Health Check, only one-fifth 
were newly prescribed statins. Low NHS Health Check 
programme coverage and statin prescribing may be 
exacerbated by higher rates of non-attendance (did 
not attend, DNA) associated with phlebotomy testing.9 
Although the use of POCT may lead to better coverage 
and higher rates of statin prescribing, POCT is not 
uniformly used.
The primary aim of this analysis was to investigate a 
range of NHS Health Check screening scenarios to deter-
mine if routine use of POCT is less costly than laboratory 
testing to the NHS.
MethODs
Data collection from contracted laboratory service
Data were sought from a local pathology services labora-
tory that provides services to GPs in Northwest London to 
illustrate various elements and costs. Data were collected 
on number and breakdown of various tests requested 
from GPs, internal and external costs of tests, transport/
courier costs (2013–2014), cost of consumables (2013–
2014) and other infrastructure costs (2013–2014).
GP recruitment
We collected data on NHS Health Check delivered at nine 
GPs (n=7 using POCT; n=2 not using POCT) between 
September 2013 and August 2014. Nine GPs (eight 
using TPP SystmOne and one using EMIS Web) with a 
combined list size of 71 500 patients (median=7009) were 
recruited from four Clinical Commissioning Group local-
ities in Northwest London. Two practices offered NHS 
Health Check in the traditional ‘laboratory model’ (LAB) 
whereby blood samples are processed overnight in a 
pathology services laboratory either following delivery of 
the sample to the pathology laboratory (LAB-1 pathway) 
or following phlebotomy in secondary care (LAB-2 
pathway). Seven practices used the Alere Cholestech 
LDX Analyzer POC device to measure total cholesterol 
and glucose levels following a pin prick blood sample to 
inform results of the NHS Health Check. Practices using 
POCT for this purpose were each loaned a device free of 
charge by the Public Health England Local Area Team 
(PHE LAT) in a bid to increase uptake of NHS Health 
Check in their locality. The cost range of the POC device 
used in the analysis was £950–£1500. Data on practice list 
size, number of patients eligible for NHS Health Check, 
uptake rate, practice workforce configuration, patient 
flow and other relevant parameters were recorded for 
each practice. The lineage, nature and time required for 
each procedure undertaken to enable a Health Check 
leading up to CVD risk score presentation was recorded, 
described and timed on three separate occasions resulting 
in a process map illustrating typical patient journey in 
either Health Checks delivery model. Aggregate, quan-
titative and non-patient-identifiable (ie, pseudonymised) 
data were collected from each participating practice.
unDerstAnDInG PAtIent flOw AnD PrOcess tIMes tO 
ADMInIster An nhs heAlth check
GP staff were asked to describe how patients are iden-
tified and invited and what processes were involved in 
administering the NHS Health Check in each respective 
practice. Three mock NHS Health Check were conducted 
for each pathway to enable measurement of each relevant 
procedure. The total average time required to deliver 
each component of the Health Check in the primary 
care setting was measured and expressed in minutes and 
seconds, resulting in a total average time to conduct a 
Health Check in either POCT or LAB pathway.
cOnfIrMInG cOMPlIAnce Of GP tO Phe cAre quAlIty 
crIterIA fOr usInG POct
All seven GPs using POCT were assessed against the four 
PHE Care Quality Criteria for using POCT10 to confirm 
that (1) relevant staff have been trained, (2) that there 
is a named POCT coordinator at each practice, (3) that 
an appropriate internal quality control process is in place 
and (4) that each POCT location is registered.
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rAte Of nOn-resPOnse tO InItIAl InvIte AnD rAte Of 
MIsseD fOllOw-uP nhs heAlth check APPOIntMents
Data on the number of patients who do not respond (DNR) 
to NHS Health Check invite letters and the number of 
patients who ultimately DNA initial or follow-up appoint-
ment are not routinely collected by GPs or PHE LAT. To 
address this gap in knowledge, four GPs (two using POCT 
and two using laboratory pathway) were commissioned to 
identify and invite up to 450 eligible patients who have 
not yet received an initial NHS Health Check invite letter. 
Practices were asked to record response rates to invite 
letter and rates of subsequent attendance or missed 
appointments to facilitate calculation of actual DNR and 
DNA rates for use in mathematical model using micro-
costing approach.
Although all four practices identified eligible patients 
and sent out invite letters, only two practices using 
POCT reported their findings. Recording response 
rates was very time consuming for practices using the 
laboratory pathway. These practices cited ‘conflicting 
priorities’, ‘resources issues’ and ‘practicalities’ in 
completing this specific component of the study. The 
number of patients who did not respond (DNR) to 
the initial invite letter was recorded by two GPs using 
POCT. The two GPs using POCT invited a total of 826 
eligible patients, of which 75 patients completed an 
NHS Health Check within 4 months of initial invite. 
The average DNR rate following initial mail of either 
batch of invite letters from POCT practices was 90.2%. 
Although data on patients responding to invites from 
laboratory practices were not available, the DNR rate 
is expected to be similar for all practices (regardless if 
they use POCT or not) in the same area with similar 
demography attempting to engage with the same repre-
sentative sample population. In view of this, DNR rates 
for both POCT and non-POCT practices were assumed 
to be the same, and an average value for DNR of 90.2% 
was used in the analysis.
The average percentage of patients who responded to 
the invite letter and proceeded to book an appointment 
but ultimately DNA their NHS Health Check appoint-
ment in POCT practices was 10.6%. For the subsequent 
steps where DNA is possible with laboratory pathway 
(ie, phlebotomy appointment, scheduled Health Check 
appointment for baseline data collection and second 
visit to learn about CVD risk score), a DNA rate of 5% 
at each bifurcation in the process tree was assumed. 
The choice of the 5% DNA has been made using the 
national data of DNA rate of 7.5% as a reference.2 
Decreasing the DNA rate to 5% (as opposed to 7.5% 
from national data) for the laboratory pathway in subse-
quent bifurcations was to mitigate the risk of penalising 
the laboratory test attendance in favour of the POCT 
pathway, which has no opportunity for subsequent DNA 
after the initial NHS Health Check appointment. There-
fore, the analysis conducted was ‘worst case’ scenario 
for POCT pathway.
Mathematical model using microcosting approach
A microcosting analysis was undertaken from the NHS 
perspective. Costs were calculated using 2013–2014 rates 
expressed in Great British Pound. As the analysis was 
performed assuming a time horizon of less than 1 year, 
the discounting of costs was deemed unnecessary.
The analysis used a decision tree to describe the options 
being compared and the possible pathways following 
them. This decision tree was based on the simplified 
flow diagram (figure 1) describing the observed process 
elements leading to an NHS Health Check in either labo-
ratory (LAB) or POCT pathway.
Costs were assessed using a microcosting approach. For 
each phase of the pathway, all resources (ie, staff, mate-
rials and consumables) were identified using data from 
laboratory engagement, GP engagement and observa-
tional data. Staff payments were estimated using the data 
on the average cost per hour in the UK from the Personal 
Social Service Research Unit 2014. The average cost per 
hour was multiplied by the time dedicated to each activity. 
The costs of the materials and consumables were assessed 
using data from the manufacturers, GPs, laboratory and 
evidence from the literature.
Because GPs do not routinely conduct an NHS Health 
Check during a consultation with patients, modelling was 
based on healthcare assistant (HCA) or nurse salary costs. 
The modelling was based on a commonly observed base 
case scenario: HCA-led Health Check with a DNR rate 
of 90.2% in both pathways, a DNA rate of 10.6% in the 
POCT and the first step of laboratory pathway and then a 
DNA rate of 5% in the following steps for the laboratory 
pathway; LAB fasting glucose measurement as opposed to 
HbA1c. The cost of the POC device (range=£950–£1500) 
and the costs of staff training on use of POCT were not 
used in the base case. The flowchart and decision tree 
are depicted in figure 1. The probabilities associated with 
each event were obtained from real-world estimations 
from two POCT practices recruited into this project.
sensItIvIty AnAlysIs
A one-way sensitivity analysis was undertaken, varying 
all input parameters to the original Base Case Scenario 
between their lower and upper values (table 1) to see how 
this would change the difference in total costs per 100 
invites and to express the results in a tornado diagram. 
We included cost of device (range=£950–£1500 divided 
by 2000 tests) and training costs (8 hours of HCA time 
divided by 2000 tests) in the sensitivity analysis.
A probabilistic sensitivity analysis was performed to 
obtain 95% credible intervals around the main results. 
This was done by carrying out 1000 simulations using 
uniform distributions for each parameter.
AlternAtIve scenArIOs
Microcosting analysis and modelling resulted in the iden-
tification of comparative cost of NHS Health Check in 
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Figure 1 Decision tree showing laboratory (model 1) and  POCT (model 2) NHS Health Check driven pathway. DNA, do not 
attend; DNR, do not spend; GP, general practice; HC, Health Check; POCT, point-of-care testing; NHS, National Health Service.
either Laboratory or POCT-driven practices to illustrate 
differences in the cost of one completed NHS Health 
Check in either pathway. We also performed the anal-
ysis for alternative scenarios: (1) cost of NHS Health 
Check assuming all patients respond to invite letter and 
complete the Health Check and (2) cost of an ‘opportu-
nistic’ NHS Health Check as described below.
cOst Of An OPPOrtunIstIc nhs heAlth check
In some cases, it is theoretically possible that a patient may 
be offered the opportunity to complete a Health Check 
‘on the spot’ after being identified as eligible following 
routine consultation or visit to general practitioners. This 
is less likely in the laboratory pathway as most patients 
will probably need to attend phlebotomy appointment 
first (laboratory-1 pathway). In case of availability of a 
recent (<3 months) blood test indicating glucose and/
or HbA1c and total cholesterol levels on the patient’s 
electronic health record (EHR), it would be possible for 
the patient to complete an ‘opportunistic’ Health Check 
(laboratory-2 pathway) pending availability of nurse or 
HCA. Because no information on the number of patients 
that would be offered an opportunistic Health Check or 
how many patients would DNA follow-up appointments 
in laboratory pathway was available, the total expected 
cost (TEC) of these options could not be calculated in 
the main model. However, the costs for one patient who 
completes an opportunistic Health Check for either 
pathway could be calculated.
ethics
Ethical approval was not sought for this study as it did 
not involve recruitment of participants or use of patient 
identifiable data and other qualifying criteria. This was 
confirmed by completing the Health Research Authority 
(HRA) online decision tool for ethics, as evidenced by the 
HRA Tool Output Page.
results
Understanding patient flow and process times to administer 
an NHS Health Check
Patients undertaking an NHS Health Check in the labo-
ratory pathway have two or three opportunities to miss an 
appointment or exit the care pathway, whereas patients 
undertaking an NHS Health Check in the POCT pathway 
only had one opportunity to miss the initial appointment 
(figure 1).
The time required to conduct an NHS Health 
Check up to the point of CVD risk score calculation 
varied from practice to practice (range=20–40 min) irre-
spective of whether they were using POCT. The shortest 
time recorded was for a simulated patient undertaking 
an opportunistic Health Check assuming that recent 
(<3 month) blood results, and blood pressure readings 
were available on the patient’s EHR.
The average time required to acquire a blood sample 
was 2.5 min longer with the cannulated syringe method 
used in the laboratory pathway than via the finger pin 
prick sampling method used in the POCT pathway. Events 
related to drawing a blood sample with a cannulated 
syringe include rolling up the patient’s sleeve, applying 
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a constriction band, labelling the blood vials, disinfecting 
the injection site, inserting the cannula, attaching the 
collection vials, drawing of blood sample, removing the 
cannula, applying digital pressure followed by a plaster 
over the wound and preparing the vials for dispatch. 
Accessing a blood sample with the finger prick method 
involved fewer steps, including disinfecting the injection 
site, finger pin prick, transferring blood aliquot onto a 
cassette via capillary tube to enable measurement with 
POC device and applying a plaster to the wound area. 
The 5 min time required for the POC device to deliver the 
test results was routinely used to apply the sphygmoma-
nometer enabling further interlocution with the patient 
to drive the Health Check.
Adherence of GPs to Phe quality care criteria for using POct
All seven GPs using POCT (100%) demonstrated that 
their staff were (1) suitably trained to use POC device, 
(2) that an appropriate internal quality control process 
was in place as evidenced by daily control sample and 
monthly calibration of the POCT device and (3) that each 
POCT location was registered in an accredited External 
Quality Assessment Programme. Only five (71%) of seven 
practices confirmed that they had a nominated POCT 
coordinator. The overall score for compliance to the four 
PHE Quality Care Criteria for Using POCT was 92% for 
all seven practices.
results of the model
Without taking into account DNR and DNA rates, one 
entire Health Check in the laboratory pathway would cost 
£22.32 (£3.28 for the response to the letter and sending a 
phlebotomy request, £1.02 for scheduling a phlebotomy 
appointment, £10.33 for phlebotomy and blood tests, 
£1.02 for scheduling the Health Check appointment and 
£6.67 for the final Health Check appointment). One 
entire Health Check in the POCT pathway would cost 
£17.04 (£1.02 for the response to the letter and sched-
uling the Health Check appointment and £16.02 for the 
Health Check appointment including POCT blood tests). 
Therefore, without taking into account DNR and DNA, 
one completed Health Check using POCT would cost 
£5.28 less than one completed using laboratory pathway.
Because of the higher number of visits needed for 
the laboratory pathway, there is a higher risk of subse-
quent DNA for the entire pathway compared with POCT 
pathway, which delivers the Health Check in one sitting. 
The calculated number of completed Health Checks per 
100 invites and the costs per one completed Health Check 
are shown in table 2. The TEC of NHS Health Check per 
100 patients in the base case scenario was £29 lower (95% 
credible interval=−£244 to £95) in POCT-led pathway 
than in laboratory pathway. The TEC per one completed 
Health Check was £7 lower in the POCT pathway 
(TEC=18) than in the laboratory pathway (TEC=£25) 
when DNA and DNR rates are taken into account.
One-way sensitivity analysis
The value of each parameter was varied between the lower 
and the upper values to check how this would influence 
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Table 2 Base case scenario showing total expected cost (TEC, number of completed Health Checks and costs per 
completed Health Check per 100 invites (including 95% credible intervals from probabilistic sensitivity analysis (PSA))
Model TEC (range)
No. of NHS Health Check 
completed (range)
TEC per completed NHS Health 
Check (range)
LAB-led £189.00 (£164 to £561) 7.50 (5.0 to 10.7) £25 (£25 to £51)
POCT-led £160.00 (£117 to £354) 8.74 (5.8 to 11.9) £18 (£17 to £36)
Difference −£29 (−£244 to £95) 1.25 (−3.6 to 5.5) −£7 (−£23 to −£2)
NHS, National Health Service; POCT, point-of-care testing; TEC, total expected cost.
Figure 2 Tornado diagram showing the 10 parameters 
with the largest influence on the difference in costs per 100 
invites. HC, health care; HCA, healthcare assistant; POCT, 
point-of-care testing.
the difference in TECs per 100 invites. The tornado 
diagram (figure 2) shows the 10 parameters with the 
largest influence on the results. Only three parameters 
had a large enough impact on the results to change the 
difference from negative to positive rendering the POCT 
model more expensive in this case.
When the response to the invitation in laboratory 
pathway was low or the response to the invitation in POCT 
pathway was high, total costs per 100 invites were higher 
for POCT. In this case, the number of completed Health 
Checks in the POCT pathway was higher, and the costs 
per completed Health Check were equal to the base case.
When the HCA or nurse time for the Health Check 
was high, the total costs per 100 invites were higher for 
POCT than for the LAB model, the number of completed 
Health Checks was the same as in the base case and the 
cost per completed Health Check for POCT was higher 
than that in the base case (up to £22) but still lower than 
that in the LAB model.
Alternative scenarios
cost of health check assuming all patients respond to invite 
letter and complete the health check
If we assume all invited persons would respond in both 
the laboratory pathway and the POCT pathway, but some 
people would drop out of the pathway because of missed 
appointments (ie, DNR rate is 0%, but DNA rate as in the 
base case model), 77 Health Checks would be completed 
in the laboratory pathway compared with 89 in the POCT 
pathway. The TEC per one completed Health Check 
would be the same as when taking into account observed 
DNR rates (TEC= £25 for Laboratory and £18 for POCT; 
table 3).
cost of opportunistic health checks
The costs for one patient who completes an opportu-
nistic NHS Health Check for either pathway are shown 
in table 4. The costs for an opportunistic health check 
via laboratory-1 pathway (ie, phlebotomy at GP) would be 
£21.67, which is effectively the costs of the normal labora-
tory pathway minus the costs of sending a letter with the 
phlebotomy request (£0.65/patient). An opportunistic 
Health Check in laboratory-2 pathway (ie, no phlebotomy 
indicated as recent blood results are available on patient’s 
EHR) would cost £7.69 less. An opportunistic Health 
Check using POCT would cost the same as the normal 
POCT pathway (£17.04). For all opportunistic Health 
Checks, the costs of sending an invitation letter (calcu-
lated at £21.93 per 100 invites, but not included in the 
main model because it applies to all pathways) can be 
omitted.
Discussion
This is the first study using a cost-minimisation analysis 
to investigate the potential cost-saving use of POCT in 
delivering NHS Health Check in the primary care setting. 
According to the results of the mathematical model, the 
cost savings to the NHS associated with POCT were esti-
mated at £29 per 100 patients.
The total excepted cost of a POCT-driven NHS Health 
Check in GP was likely to be lower than the traditional 
laboratory pathway up to the point of CVD risk score 
presentation. This applied to all scenarios, including 
those scenarios that factored in the cost of the device 
and the cost of staff training on use of POCT, both when 
looking at the cost of a Health Check for 100 patients, 
and the per-patient cost for one completed Health Check. 
The only exception to this was when a patient was offered 
an opportunistic Health Check following a routine 
consultation visit to the GP where the patient’s EHR indi-
cated recent (<3 months) blood results for glucose and/
or HbA1c and cholesterol levels (£7.69 for laboratory vs 
£17.04 for POCT). A 4-year study found 25% of Health 
Checks completed in GP to result from opportunistic 
recruitment with 75% of all Health Checks completed 
using prescheduled appointments.11 It is unknown what 
proportion of all NHS Health Check are delivered using 
POC testing.
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Table 3 Alternative scenario showing total expected cost (TEC costs, number of completed health checks and costs per 
completed health check per 100 invites assuming all patients respond to invite letter
Model
Alternative scenario assuming all patients respond to invite letter
Total Expected Costs (TEC)
No of NHS Health Check 
completed
TEC per completed NHS Health 
Check
LAB-led £1932 76.62 £25
POCT-led £1640 89.37 £18
Difference −£292 12.75 −£7
NHS, National Health Service; POCT, point-of-care testing; TEC, total expected cost.
Table 4 Costs for one patient completing an opportunistic NHS Health Check at GP in either pathway
Event
Laboratory-1
(phlebotomy)
Laboratory-2
(no phlebotomy at GP)
POCT
(via pin prick sample)
GP hands out a phlebotomy 
request
£2.63 – –
Schedule phlebotomy 
appointment
£1.02 – –
Phlebotomy £10.33 – –
Schedule health check £1.02 £1.02 £1.02
CVD risk score presentation £6.67 £6.67 £16.02
Total cost £21.67 £7.69 £17.04
CVD, cardiovascular disease; GP, general practitioner; NHS, National Health Service; POCT, point-of-care testing.
There is wide variation in how the NHS Health Check 
Programme is currently being delivered.11 This study 
illustrated a number of possible entry points that would 
enable a patient to undertake an NHS Health Check in 
GP (figure 1). However, in contradistinction to the POCT 
pathway which delivers the Health Check in one sitting, 
the number of bifurcations in the laboratory pathway 
imply that patients have three times more opportunities to 
miss a health check-related appointment. Missed appoint-
ments represent a significant burden on NHS resources,12 
with up to 9% of total outpatient appointments missed 
in 2014–1513. While it is difficult to establish the exact 
financial impact of missed GP appointments, missed first 
outpatient appointments were estimated to cost the NHS 
up to £225 million in 2012–1314. Use of POCT to deliver 
NHS Health Check in one sitting could result in fewer 
missed GP or outpatient/phlebotomy appointments with 
cost savings from the NHS perspective.
cost minimisation using POct for routine nhs health check
There is much interest in reducing costs and in improving 
overall effectiveness of CVD screening, and the NHS 
Health Check Programme is the first such national 
CVD risk assessment and management programme in 
England. The Department of Health’s modelling of the 
programme’s cost-effectiveness was based on the assump-
tion that the NHS Health Check programme would be 
widely implemented with good overall uptake.6 However, 
a 4-year evaluation of the NHS Health Check programme 
reported low coverage (21.4%) suggesting that there 
is significant room for improvement in delivering the 
programme more effectively.15 A wide variation in 
coverage between English regions (9.4% to 30.7%) and 
between GPs (0% to 72.7%) and among ethnic minorities 
suggests that the programme is not delivered equitably 
throughout England.8 By lowering the opportunity for 
missed appointments, POCT may offer an effective way 
to increase coverage while also reducing costs associated 
with missed appointments.
A recent evaluation of New Zealand's Heart Check 
Programme (NZHCP) showed that whereas the coverage 
rate was initially poor, the programme eventually met its 
national target coverage rate of 90% following a series 
of patient engagement initiatives coupled to effective 
use of IT.16 The evaluation identified the need for blood 
tests as an impediment to slow uptake initially, and case 
studies involving  the use of POCT to support NZHCP 
were deemed effective. However, use of POCT in NZHCP 
was considered too expensive from the perspective of the 
provider, although it is unknown whether this conclusion 
resulted from a cost-minimisation analysis.16
In the present analysis, we assumed that a Health 
Check would require a minimum time of 20 min (lower 
limit) and up to 40 min (upper limit). The mathematical 
model assumed a base case of 20 min for the laboratory 
pathway and 30 min for the POCT pathway. The discrep-
ancy, which was in favour of the laboratory pathway, was 
included because we acknowledged that not all patients 
in the laboratory pathway will have a blood test at the GP 
(i.e, some patients will have phlebotomy in pathology 
services laboratory). We also assumed 5% DNA rate for 
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subsequent Health Check-related appointments in the 
laboratory pathway as opposed to 7.9% national average 
rate in order to not penalise this pathway. In spite of 
this, and considering that the costs of POC devices with 
similar capabilities are likely to decrease as technology 
and related markets develop further, the results of this 
cost-minimisation analysis, which represent a ‘worst case’ 
scenario for POCT pathway, are still in favour of using 
POC to support NHS Health Check in the primary care 
setting from the NHS perspective.
extant barriers for widespread adoption of POct to drive nhs 
health check
The findings of this study illustrated routine use of POCT 
in GP to support NHS Health Check in the contempo-
rary setting, with good overall compliance of the GPs to 
the four PHE Care Quality Criteria for using POCT.10 
However, there are a number of extant barriers to the 
widespread adoption and diffusion of POCT in primary 
care generally,17–19 including current reimbursement 
models and misaligned incentives.17 Whereas other 
barriers such as prevailing attitudes of healthcare prac-
titioner or a preference to use laboratory services over 
POCT can be overcome with relatively minor changes to 
work pattern, structural barriers including the lack of a 
suitable funding and reimbursement model will require 
policy change if widespread NHS adoption is to be 
achieved.17 20 Evidence of cost savings to the NHS from 
using POCT may provide a rationale for a change in the 
current reimbursement model and incentives to GPs in 
favour of wider adoption and use of POCT for specified 
purposes. POC device manufacturers could also offer a 
discounted pricing policy for test panels to increase their 
market presence and to overcome the perceived test 
cost procurement barrier when introducing POCT more 
extensively within the NHS for specific purposes.21 The 
recently proposed changes to the NHS Pathology tariff 
are likely to positively affect the general adoption and 
diffusion of POCT in the UK. However, further research 
is needed to develop scaling-up strategies to address the 
resourcing, clinical governance and economic impact 
of widespread NHS implementation for the purpose 
of supporting NHS Health Check in the primary care 
settingP.
Implications of the study
By facilitating screening in a single visit while offering 
satisfactory accuracy of testing, POCT has clear advan-
tages over the laboratory-based approaches, which may 
be time consuming.22 POCT also carries the potential 
of improved patient care, with lower recurrent hospital 
admissions and economic savings for preventable chronic 
conditions.20 23 These patient benefits may occur in the 
hospital setting, in GP, in the community setting and in 
remote areas.6 23 24 There is growing interest internation-
ally and in the UK among clinicians to use POC testing to 
help diagnose a range of acute and chronic conditions25 
and in supporting antibiotic stewardship.17 26–28 However, 
unless the cost of the tests (including equipment, 
consumables and time) were fully reimbursed, the prac-
tice could lose money from using POCT.17 This is one of 
the factors that has hindered the uptake of POCT in the 
primary care setting in England.
This study shows that the NHS Health Check 
programme would cost less from the NHS perspective if 
POCT was used  at scale. Future large-scale public health 
screening programmes should ideally consider a disrup-
tive commissioning model that includes reimbursement 
and other incentives to affect the large-scale adoption of 
suitable multi-array POC devices in GP with the potential 
to reduce costs from the NHS perspective.
Low statin prescribing to people at increased CVD 
risk and variation in statin prescribing among GPs also 
highlights the need for better follow-up of patients.8 9 29 
Because CDV risk score is available immediately following 
a Health Check with POCT, it could potentially expedite 
the timely prescription of statins to patients identified to 
be at high CVD risk during a routine or follow-up appoint-
ment with GP or prescribing clinician.
Advances in technology and miniaturisation could result 
in more affordable POC devices with added function-
ality to support different clinic needs in routine general 
practice. Competitive behaviour between POC device 
manufacturers could lead to lower costs and increased 
quality of base unit and consumables, making POC more 
affordable from the NHS perspective. Use of POCT to 
support delivery of NHS Health Check in one sitting may 
also be more convenient from the patient’s perspective as 
this diminishes the need for subsequent visits and may be 
preferred by patients who are needle-phobic and avert to 
having a blood test using the cannulated syringe method.9
limitations of study
The principle limitation of this study was the lack of 
availability of data for subsequent DNA rates in the labora-
tory-led pathway. However, an evidence-based assumption 
was used to for subsequent DNA rates with a fixed value 
of 5%, which is significantly lower than the observed rate 
of DNA in POCT pathway and lower than the national 
average rate of missed appointments. The results of this 
analysis are conservative in showing the savings associ-
ated with POCT, which may be higher if subsequent DNA 
rates are above 5%, as is likely to be the case. Further, 
whereas this study employed the use of a mathematical 
model with a microcosting approach, future studies could 
determine if use of POCT to deliver NHS Health Check 
is cost-effective from the NHS perspective by taking into 
account other variables and outcome measures post CVD 
risk score presentation.
conclusion
A cost-minimisation analysis using a mathematical model 
with alternative scenarios showed that the total expected 
cost of using POCT to deliver a routine NHS Health 
Check in the primary care setting up to the point of 
CVD risk score presentation is lower than the laborato-
ry-led pathway from the NHS perspective. Laboratory-led 
pathway offers patients three times more opportunities 
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to miss subsequent NHS Health Check-related appoint-
ments or to exit the care pathway compared with POCT 
pathway. Using POCT in this context could be more 
convenient for patients and offers GPs the ability to act 
as a ‘one stop shop’ to patients by delivering a complete 
NHS Health Check in a single sitting. Using POCT in 
routine general practice for this purpose will likely reduce 
overall programme costs while supporting an increase in 
coverage from existing levels.
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